Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Intellia Therapeutics Inc (NTLA)

  • Business News
  • Nov. 10, 2025, 20:17 UTC
  • 15
  • 1 comments

Intellia Therapeutics Presents Positive Longer-Term Phase 1 Data of Nexiguran Ziclumeran (nex-z) in Patients with Transthyretin (ATTR) Amyloidosis with Cardiomyopathy

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 10, 2025, 19:58 UTC
  • 16
  • 1 comments

Walmart Black Friday 2025: Everything You Need to Know

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 10, 2025, 19:45 UTC
  • 21
  • 1 comments

Baldur’s Gate 3: The Latest News and Final Updates (November 2025)

Market reaction Comment Full text

Soleno Therapeutics Inc. (SLNO)

  • Business News
  • Nov. 10, 2025, 19:45 UTC
  • 17
  • 1 comments

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 10, 2025, 19:43 UTC
  • 17
  • 1 comments

Samsung Z Flip 6: Specs, Release Date, and What to Expect in 2026

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 10, 2025, 19:41 UTC
  • 17
  • 1 comments

Can You Play PS4 Games on a PS5?

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 10, 2025, 19:41 UTC
  • 19
  • 1 comments

The Best Free PDF Editors For 2026

Market reaction Comment Full text

Arcturus Therapeutics Holdings Inc (ARCT)

  • Business News
  • Nov. 10, 2025, 19:40 UTC
  • 20
  • 1 comments

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and Encourages Investors with Substantial Losses to Contact the Firm

Market reaction Comment Full text

Inspire Medical Systems Inc. (INSP)

  • Business News
  • Nov. 10, 2025, 18:32 UTC
  • 17
  • 1 comments

Robbins Geller Rudman & Dowd LLP Announces that Inspire Medical Systems, Inc. (INSP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Market reaction Comment Full text

Imunon Inc (IMNN)

  • Business News
  • Nov. 10, 2025, 18:30 UTC
  • 8
  • 1 comments

IMUNON Public Webcast Highlights Resilience and Innovation in Pursuit of the First Approved Immunotherapy for Ovarian Cancer

Market reaction Comment Full text
  • Previous
  • 726
  • 727
  • 728
  • 729
  • 730
  • Next

Search

News categories

  • Technical Exchange News(10969)
  • Event(2441)
  • SEC News(193597)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125899)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin